Cite
Bioequivalue of two mycophenolate sodium enteric-coated tablets and the drug monitoring based on limited sampling strategy: A single-center, randomized, open-label, three-period, reference-replicated, crossover study.
MLA
Guangxun Xu, et al. “Bioequivalue of Two Mycophenolate Sodium Enteric-Coated Tablets and the Drug Monitoring Based on Limited Sampling Strategy: A Single-Center, Randomized, Open-Label, Three-Period, Reference-Replicated, Crossover Study.” Transplant Immunology, vol. 81, Dec. 2023, pp. 67–74. EBSCOhost, https://doi.org/10.1016/j.trim.2023.101923.
APA
Guangxun Xu, Zhendi Wang, Tianzhong Yan, Jinyu Li, & Xiaofeng Zhou. (2023). Bioequivalue of two mycophenolate sodium enteric-coated tablets and the drug monitoring based on limited sampling strategy: A single-center, randomized, open-label, three-period, reference-replicated, crossover study. Transplant Immunology, 81, 67–74. https://doi.org/10.1016/j.trim.2023.101923
Chicago
Guangxun Xu, Zhendi Wang, Tianzhong Yan, Jinyu Li, and Xiaofeng Zhou. 2023. “Bioequivalue of Two Mycophenolate Sodium Enteric-Coated Tablets and the Drug Monitoring Based on Limited Sampling Strategy: A Single-Center, Randomized, Open-Label, Three-Period, Reference-Replicated, Crossover Study.” Transplant Immunology 81 (December): 67–74. doi:10.1016/j.trim.2023.101923.